Novel Light-sensitive Compounds Show Promise For Cancer Therapy

Chemists have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells. The new compounds, called dye-sensitized ruthenium nitrosyls, are absorbed by cancer cells and respond to specific wavelengths of light by releasing nitric oxide, which triggers cell death.

Read the whole article on Science Daily

More from Science Daily